We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Vaginal estrogen — brand
Estradiol vaginal ring (low-dose, 90 days)
Estring is a low-dose estradiol vaginal ring — one ring releases 7.5 mcg/day for 90 days for genitourinary syndrome of menopause (vaginal dryness, painful sex, recurrent UTIs).
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-07-03
Estring is a brand-name flexible silicone vaginal ring that releases a low, steady dose of 17β-estradiol — 7.5 mcg per day — over 90 days. It is FDA-approved for the treatment of urogenital symptoms associated with postmenopausal atrophy of the vagina (such as dryness, itching, and burning) and urinary symptoms such as dysuria and urinary urgency.
The ring is about 55 mm in diameter, sits in the upper third of the vagina like a diaphragm, and is worn continuously for 3 months. At the end of 90 days you (or a clinician) remove it and insert a new ring.
Estring is one of three main vaginal estrogen delivery forms — the others are estradiol tablets (Vagifem, Yuvafem, Imvexxy) and vaginal creams (Estrace cream, Premarin cream). Estring is the option most Kindr patients choose when they want low-maintenance dosing.
The ring releases a small, steady dose of estradiol directly into the vaginal tissue, where it restores the vaginal epithelium, natural lubrication, vaginal pH, and the healthy Lactobacillus-dominant microbiome. This is what reduces dryness, painful sex (dyspareunia), and recurrent urinary tract infections associated with genitourinary syndrome of menopause (GSM).
Because the daily dose (7.5 mcg) is far below what is needed for systemic effects, serum estradiol levels stay within the postmenopausal range. This is what makes vaginal estrogen — including Estring — an option for many women who cannot take systemic HRT.
Estring is an FDA-approved brand-name product. Many Kindr patients use compounded alternatives prepared by a state-licensed 503A pharmacy when a custom dose, custom combination, or different delivery form is clinically preferable. Both pathways are available through Kindr — your provider will recommend based on your individual needs.
A true bioequivalent generic Estring (estradiol vaginal ring, 7.5 mcg/day) has been approved but has had inconsistent U.S. availability. When a generic estradiol vaginal ring is stocked at your pharmacy it is typically 40–60% less than brand-name Estring. If the generic estradiol vaginal ring is out of stock, clinically equivalent alternatives include the Vagifem 10 mcg vaginal tablet and Imvexxy 4 or 10 mcg vaginal inserts. Kindr's membership includes most vaginal estrogen options.
90 days — one Estring provides continuous low-dose estradiol for 3 months. Then you replace it with a new ring. No daily or weekly dosing to remember.
Usually not. The ring sits in the upper third of the vagina, similar to a diaphragm. Most partners cannot detect it. You do not need to remove Estring for intercourse.
No. Systemic absorption from Estring is too low to stimulate the uterine lining, so a progestogen is not required for endometrial protection at this dose.
Both are low-dose vaginal estradiol. Estring is a 90-day ring; Vagifem is a 10 mcg tablet inserted nightly for 2 weeks then twice weekly. Efficacy for dryness and painful sex is comparable; choice usually comes down to dosing preference and cost.
Brand-name Estring typically runs $250–$400 per ring cash-pay (about $80–$130/month). Generic estradiol vaginal ring, when in stock, is often 40–60% less. Many insurance plans cover it. Kindr's membership includes most vaginal estrogen options.
Many breast cancer survivors with severe GSM use low-dose vaginal estrogen with oncology input. NAMS and ACOG consider this an acceptable option in most cases, particularly when non-hormonal options have failed. Discuss with your oncologist.
Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026
Hormone therapy
Micronized Progesterone →Hormone therapy
Testosterone (low-dose, female-physiologic) →Hormone therapy
Semaglutide →GLP-1 weight care
This page is educational and is not a substitute for a clinical evaluation. Whether any medication is appropriate for you depends on your full medical history. Kindr providers make individualized prescribing decisions during a clinical visit.